Difference between revisions of "Ishigaki K, et al. J. Clin. Endocrinol. Metab. (2002) cited as Ref 133 in DOI: 10.1038/s41392-020-0110-5 (Q9396)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2002, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): J. Clin. Endocrinol. Metab., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | J. Clin. Endocrinol. Metab. | ||
| Property / Published In Name String: J. Clin. Endocrinol. Metab. / rank | |||
| + | Normal rank | ||
Revision as of 20:30, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Ishigaki K, et al. J. Clin. Endocrinol. Metab. (2002) cited as Ref 133 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Ishigaki K
0 references
2002
0 references
J. Clin. Endocrinol. Metab.
0 references
